Clinical Characteristics and Treatment Outcomes in Endogenous Cushing’s Syndrome: A 15-Year Experience from Thailand

Table 1

Subtypes of CS.

Etiology	n (%)
CD	45 (55)
Pituitary microadenoma	34
Pituitary macroadenoma	11
Adrenal CS	26 (32)
Cortisol-producing adenoma	16
ACC	4
Aldosterone-and cortisol-cosecreting adenoma	2
PBMAH	2
PPNAD	2
EAS	11 (13)
Pulmonary	6
Small cell lung cancer	2
Carcinoid (bronchial and thymic)	3
Neuroendocrine tumor, unspecified	1
Abdomen	2
Pancreatic neuroendocrine tumor	1
Pheochromocytoma	1
MTC	1
Uncertain	2

CS, Cushing’s syndrome; CD, Cushing’s disease; ACC, adrenocortical carcinoma; PBMAH, primary bilateral macronodular adrenal hyperplasia; PPNAD, primary pigmented nodular adrenocortical disease; EAS, ectopic ACTH syndrome; and MTC, medullary thyroid carcinoma.